Greg Mankiw’s blog alerted me to a report by the US Congressional Budget Office on the Pharmaceutical Industry.
It is certainly worth a read, and tries really hard to appear unbiased, presenting facts from both the supporters and critics of the industry. Every now and then, however, it dismisses the criticisms too quickly.
Regardless, I like how Greg Mankiw summarizes the industry:
Note to Ec 10 students: We will study industries with these features–high fixed costs and price well above marginal cost–later in the semester under the topic “Monopolistic Competition.”
My previous posts on this topic ring a similar bell.
Discussion
Start a discussion for “US Pharma Industry Report”
Post a comment